Clinical Trial Update: Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis [Phase 2, Phase 3]

View source ↗

Summary

The trial compared standard versus alternative dosing of antimonial therapy for American cutaneous leishmaniasis and has completed Phase 2/3. The results could …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• American Cutaneous Leishmaniasis

Drugs mentioned

• Meglumine antimoniate (meglumine antimoniate)

Snippet

Sponsor: Oswaldo Cruz Foundation | Conditions: Cutaneous Leishmaniasis | Phase 2, Phase 3 | Status: COMPLETED